Australia's Microba Life Sciences jumps on distribution deal with Sonic Healthcare
** Shares of Microba Life Sciences MAP.AX jump as much as
5% to A$0.315
** Co and Sonic Healthcare SHL.AX sign commercial
agreement for distribution of MAP's infectious disease test
MetaPanel
** Metapanel can identify multiple pathogens simultaneously
from a single sample and was developed in partnership with
Australian hospitals
** SHL owns 23.16% stake in MAP
** Stock down ~9.8%% since ASX debut earlier this year as of
last close
(Reporting by Harish Sridharan in Bengaluru)
((harish.sridharan@thomsonreuters.com))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement